Medical aesthetics company Amedica Group has added the new Nordyx threads and Light Eyes Ultra to its portfolio.
The threads use PLACL material which combines polycaprolacton (PCL) and polylactic acid (PLLA) together. The threads aim to stimulate the production of collagen, elastin, capillaries and hyaluronic acid within the skin due to the PLACL material, resulting in restored facial volume and smoother deep lines and wrinkles, explains Amedica Group.
The company have also introduced the Light Eyes Ultra, a mesotherapy treatment to help rejuvenate and refresh the under-eye area. The injectable aims to increase circulation and brighten the eye area. It targets concerns such as eye bags and dark circles to wrinkles and dehydrated skin. Ingredients include a mixture of vitamins, amino acids and minerals to improve dermal elasticity and the periocular area, explains the company.
Linn Emilie, managing director of Amedica Group said, “At Amedica, we want our practitioners to feel safe and know that they can treating their patients year after year using our products. Improving their patients skin quality and slowing down the ageing process without any long-term side effects. Therefore, natural results, safety and long-term skin stimulation is what we look for in all our products.”
